Abstract:Background Osteoclast plays an important role in maintaining the balance between bone anabolism and bone catabolism. The abnormality of osteoclast is closely related to osteolytic bone diseases such as osteoporosis, rheumatoid arthritis and tumor bone metastasis. Purpose We aim to search for natural compound that may suppress osteoclast formation and function. Study design In this study, we assessed the impact of Dauricine (Dau) on the formation and function of osteoclasts in vitro , as well as its potential in preventing bone loss in an ovariectomy mouse model in vivo . Methods Multiple in vitro experiments were carried out, including osteoclastogenesis, podosomal belt formation, bone resorption assay, RNA-sequencing, real-time quantitative PCR, ROS level detection, surface plasmon resonance assay, luciferase assay, and western blot. To verify the effect in vivo , an ovariectomized mouse model (OVX model) was constructed, and bone parameters were measured using micro-CT and histology. Furthermore, metabolomics analysis was performed on blood serum samples from the OVX model. Results In vitro experiments demonstrated that Dau inhibits RANKL-induced osteoclastogenesis, podosomal belt formation, and bone resorption function. RNA-sequencing results revealed that Dau significantly suppresses genes related to osteoclasts. Functional enrichment analysis indicated that Dau's inhibition of osteoclasts may be associated with NF-κB signaling pathways and reactive oxygen metabolism pathways. Molecular docking, surface plasmon resonance assay, and western blot analysis further confirm ed that Dau inhibits RANKL-induced osteoclastogenesis by modulating the ROS/NF-κB/NFATc1 pathway. Moreover, administration of Dau to OVX-induced mice validated its efficacy in treating bone loss disease. Conclusion Dau prevents OVX-induced bone loss by inhibiting osteoclast activity and bone resorption, potentially offering a new approach for preventing and treating metabolic bone diseases such as osteoporosis. This study provides innovative insights into the inhibitory effects of Dau in an in vivo OVX model and elucidates the underlying mechanism.

<i>Dunaliella salina</i>-derived peptide protects from bone loss: Isolation, purification and identification

Desalted duck egg white peptides promoted osteogenesis via wnt/β-catenin signal pathway

Novel Antiosteoporotic Peptides Purified from Protein Hydrolysates of Taihe Black-Boned Silky Fowl: by Larval Zebrafish Model and Molecular Docking.

Absorption and transport properties of a codfish-derived peptide and its protective effect on bone loss in ovariectomized mice

12-Deoxyphorbol 13-Acetate Inhibits RANKL-induced Osteoclastogenesis Via the Attenuation of MAPK Signaling and NFATc1 Activation

Penicopeptide A (PPA) from the deep-sea-derived fungus promotes osteoblast-mediated bone formation and alleviates ovariectomy-induced bone loss by activating the AKT/GSK-3β/β-catenin signaling pathway

Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.

Alamandine attenuates ovariectomy-induced osteoporosis by promoting osteogenic differentiation via AMPK/eNOS axis

A Novel Atlantic Salmon (salmo Salar) Bone Collagen Peptide Delays Osteoarthritis Development by Inhibiting Cartilage Matrix Degradation and Anti-Inflammatory

Aqueous Extract of Salvia miltiorrhiza Bunge- Radix Puerariae Herb Pair Attenuates Osteoporosis in Ovariectomized Rats Through Suppressing Osteoclast Differentiation

Structural characterisation of deer sinew peptides as calcium carriers, their promotion of MC3T3-E1 cell proliferation and their effect on bone deposition in mice

Dalbergioidin (DAL) Protects MC3T3-E1 Osteoblastic Cells Against H2O2-induced Cell Damage Through Activation of the PI3K/AKT/SMAD1 Pathway

Peptide TQS169 Prevents Osteoporosis in Rats by Enhancing Osteogenic Differentiation and Calcium Absorption

In vitro and in vivo studies on exogenous polyamines and α-difluoromethylornithine to enhance bone formation and suppress osteoclast differentiation

Osteogenic Activities of Four Calcium-Chelating Microalgae Peptides

Blue Mussel-Derived Peptides PIISVYWK and FSVVPSPK Trigger Wnt/β-Catenin Signaling-Mediated Osteogenesis in Human Bone Marrow Mesenchymal Stem Cells

Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators

Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity

Antiosteoporotic Effects of Huangqi Sanxian Decoction in Cultured Rat Osteoblasts by Proteomic Characterization of the Target and Mechanism

Attenuative effects of collagen peptide from milkfish (Chanos chanos) scales on ovariectomy-induced osteoporosis

Dolichos Lablab Linné Inhibits Bone Density Loss and Promotes Bone Union in Senile Osteoporosis through Osteogenesis